Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5 JPY
−1.29 B JPY
610.12 M JPY
234.68 M
About ONCOTHERAPY SCIENCE INC
Sector
Industry
Headquarters
Kawasaki
Website
Founded
2001
ISIN
JP3202150003
FIGI
BBG000C17N14
OncoTherapy Science, Inc. engages in the research and development of antibody drugs. The firm operates through the following business segments: Drug Research and Development and Related Business, and Cancer Precision Medicine Related Business. The Drug Research and Development and Related Business segment includes drug discovery research in various fields, such as small molecule drugs, cancer peptide vaccines, and antibody drugs, and clinical trials based on the results of drug discovery research. The Cancer Precision Medicine Related Business segment engages in joint research and commercialization of detailed genetic analysis services of cancer cells (whole genome sequence analysis, neoantigen analysis, neoantigen dendritic cell therapy, etc.), large-scale analysis tests of cancer genes such as liquid biopsy for the early detection of cancer cells in the blood, as well as analysis services such as TCR/BCR repertoire analysis and immune response analysis. The company was founded on April 6, 2001 and is headquartered in Kawasaki, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4564 is 31 JPY — it hasn't changed in the past 24 hours. Watch ONCOTHERAPY SCIENCE INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange ONCOTHERAPY SCIENCE INC stocks are traded under the ticker 4564.
4564 stock has fallen by −8.82% compared to the previous week, the month change is a −8.82% fall, over the last year ONCOTHERAPY SCIENCE INC has showed a 34.78% increase.
4564 reached its all-time high on Jan 21, 2004 with the price of 1,453 JPY, and its all-time low was 15 JPY and was reached on May 13, 2024. View more price dynamics on 4564 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4564 stock is 6.67% volatile and has beta coefficient of −0.32. Track ONCOTHERAPY SCIENCE INC stock price on the chart and check out the list of the most volatile stocks — is ONCOTHERAPY SCIENCE INC there?
Yes, you can track ONCOTHERAPY SCIENCE INC financials in yearly and quarterly reports right on TradingView.
ONCOTHERAPY SCIENCE INC is going to release the next earnings report on Feb 10, 2025. Keep track of upcoming events with our Earnings Calendar.
4564 net income for the last quarter is −243.41 M JPY, while the quarter before that showed −302.29 M JPY of net income which accounts for 19.48% change. Track more ONCOTHERAPY SCIENCE INC financial stats to get the full picture.
No, 4564 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 4, 2024, the company has 54.00 employees. See our rating of the largest employees — is ONCOTHERAPY SCIENCE INC on this list?
Like other stocks, 4564 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONCOTHERAPY SCIENCE INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ONCOTHERAPY SCIENCE INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ONCOTHERAPY SCIENCE INC stock shows the sell signal. See more of ONCOTHERAPY SCIENCE INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.